CLEANSPARK INC (CLSK) Stock Fundamental Analysis

NASDAQ:CLSK • US18452B2097

9.95 USD
-0.49 (-4.69%)
At close: Feb 27, 2026
9.93 USD
-0.02 (-0.2%)
After Hours: 2/27/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall CLSK gets a fundamental rating of 3 out of 10. We evaluated CLSK against 274 industry peers in the Software industry. CLSK has a bad profitability rating. Also its financial health evaluation is rather negative. CLSK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • CLSK had negative earnings in the past year.
  • CLSK had a negative operating cash flow in the past year.
  • In the past 5 years CLSK reported 4 times negative net income.
  • In the past 5 years CLSK reported 4 times negative operating cash flow.
CLSK Yearly Net Income VS EBIT VS OCF VS FCFCLSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M -600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -8.03%, CLSK is doing worse than 60.95% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -19.32%, CLSK is doing worse than 60.22% of the companies in the same industry.
Industry RankSector Rank
ROA -8.03%
ROE -19.32%
ROIC N/A
ROA(3y)-4.88%
ROA(5y)-6.86%
ROE(3y)-4.21%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
CLSK Yearly ROA, ROE, ROICCLSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

1.3 Margins

  • With a Gross Margin value of 53.08%, CLSK is not doing good in the industry: 67.88% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of CLSK has grown nicely.
  • CLSK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7%
GM growth 5Y21.34%
CLSK Yearly Profit, Operating, Gross MarginsCLSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CLSK has been increased compared to 1 year ago.
  • The number of shares outstanding for CLSK has been increased compared to 5 years ago.
  • CLSK has a worse debt/assets ratio than last year.
CLSK Yearly Shares OutstandingCLSK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CLSK Yearly Total Debt VS Total AssetsCLSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 1.16, we must say that CLSK is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.16, CLSK is in line with its industry, outperforming 40.51% of the companies in the same industry.
  • CLSK has a Debt/Equity ratio of 1.29. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.29, CLSK is not doing good in the industry: 79.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Altman-Z 1.16
ROIC/WACCN/A
WACC10.52%
CLSK Yearly LT Debt VS Equity VS FCFCLSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 10.54 indicates that CLSK has no problem at all paying its short term obligations.
  • The Current ratio of CLSK (10.54) is better than 94.53% of its industry peers.
  • CLSK has a Quick Ratio of 10.54. This indicates that CLSK is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 10.54, CLSK belongs to the best of the industry, outperforming 94.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.54
Quick Ratio 10.54
CLSK Yearly Current Assets VS Current LiabilitesCLSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • CLSK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -237.18%.
  • CLSK shows a strong growth in Revenue. In the last year, the Revenue has grown by 67.96%.
  • CLSK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 138.17% yearly.
EPS 1Y (TTM)-237.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)67.96%
Revenue growth 3Y79.95%
Revenue growth 5Y138.17%
Sales Q2Q%11.63%

3.2 Future

  • CLSK is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -68.41% yearly.
  • CLSK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.19% yearly.
EPS Next Y-115.57%
EPS Next 2Y-41.72%
EPS Next 3Y-68.41%
EPS Next 5YN/A
Revenue Next Year7.99%
Revenue Next 2Y13.31%
Revenue Next 3Y28.19%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CLSK Yearly Revenue VS EstimatesCLSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CLSK Yearly EPS VS EstimatesCLSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • CLSK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLSK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLSK Price Earnings VS Forward Price EarningsCLSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800 -1K

4.2 Price Multiples

  • CLSK's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CLSK is cheaper than 87.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.55
CLSK Per share dataCLSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • CLSK's earnings are expected to decrease with -68.41% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.72%
EPS Next 3Y-68.41%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CLSK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLEANSPARK INC

NASDAQ:CLSK (2/27/2026, 8:00:00 PM)

After market: 9.93 -0.02 (-0.2%)

9.95

-0.49 (-4.69%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners79.25%
Inst Owner Change4.21%
Ins Owners1.72%
Ins Owner Change17.07%
Market Cap2.54B
Revenue(TTM)785.19M
Net Income(TTM)-267.04M
Analysts82.86
Price Target24.56 (146.83%)
Short Float %32.83%
Short Ratio2.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.04
Dividend Growth(5Y)N/A
DP-4.17%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-290.57%
Min EPS beat(2)-478.1%
Max EPS beat(2)-103.04%
EPS beat(4)1
Avg EPS beat(4)-203.45%
Min EPS beat(4)-478.1%
Max EPS beat(4)171.26%
EPS beat(8)3
Avg EPS beat(8)6.91%
EPS beat(12)6
Avg EPS beat(12)-7.59%
EPS beat(16)7
Avg EPS beat(16)-28.99%
Revenue beat(2)0
Avg Revenue beat(2)-7.91%
Min Revenue beat(2)-8.67%
Max Revenue beat(2)-7.15%
Revenue beat(4)1
Avg Revenue beat(4)-5.68%
Min Revenue beat(4)-8.67%
Max Revenue beat(4)0.51%
Revenue beat(8)3
Avg Revenue beat(8)-2.55%
Revenue beat(12)4
Avg Revenue beat(12)-2.03%
Revenue beat(16)5
Avg Revenue beat(16)-3.78%
PT rev (1m)-0.71%
PT rev (3m)-2.54%
EPS NQ rev (1m)-570.48%
EPS NQ rev (3m)-141.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-116.69%
Revenue NQ rev (1m)-15.46%
Revenue NQ rev (3m)-37.72%
Revenue NY rev (1m)1.36%
Revenue NY rev (3m)-22.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.24
P/FCF N/A
P/OCF N/A
P/B 1.84
P/tB 2.04
EV/EBITDA 10.55
EPS(TTM)-1.07
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-2.56
FCFYN/A
OCF(TTM)-1.97
OCFYN/A
SpS3.07
BVpS5.4
TBVpS4.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.03%
ROE -19.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.08%
FCFM N/A
ROA(3y)-4.88%
ROA(5y)-6.86%
ROE(3y)-4.21%
ROE(5y)-6.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7%
GM growth 5Y21.34%
F-Score2
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Debt/EBITDA 8.05
Cap/Depr 38.96%
Cap/Sales 19.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.54
Quick Ratio 10.54
Altman-Z 1.16
F-Score2
WACC10.52%
ROIC/WACCN/A
Cap/Depr(3y)67.81%
Cap/Depr(5y)346.78%
Cap/Sales(3y)33.73%
Cap/Sales(5y)94.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-237.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-115.57%
EPS Next 2Y-41.72%
EPS Next 3Y-68.41%
EPS Next 5YN/A
Revenue 1Y (TTM)67.96%
Revenue growth 3Y79.95%
Revenue growth 5Y138.17%
Sales Q2Q%11.63%
Revenue Next Year7.99%
Revenue Next 2Y13.31%
Revenue Next 3Y28.19%
Revenue Next 5YN/A
EBIT growth 1Y-167.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-20.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-306.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-565.42%
OCF growth 3YN/A
OCF growth 5YN/A

CLEANSPARK INC / CLSK FAQ

What is the ChartMill fundamental rating of CLEANSPARK INC (CLSK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CLSK.


What is the valuation status of CLEANSPARK INC (CLSK) stock?

ChartMill assigns a valuation rating of 1 / 10 to CLEANSPARK INC (CLSK). This can be considered as Overvalued.


Can you provide the profitability details for CLEANSPARK INC?

CLEANSPARK INC (CLSK) has a profitability rating of 1 / 10.


What is the earnings growth outlook for CLEANSPARK INC?

The Earnings per Share (EPS) of CLEANSPARK INC (CLSK) is expected to decline by -115.57% in the next year.


Is the dividend of CLEANSPARK INC sustainable?

The dividend rating of CLEANSPARK INC (CLSK) is 0 / 10 and the dividend payout ratio is -4.17%.